Daniel Wojdyla

25.0k citations
245 papers · 17.0k indexed · 8 hit papers · h-index 56

Impact in

Papers in

    • Atrial Fibrillation Management and Outcomes 69
    • Antiplatelet Therapy and Cardiovascular Diseases 50
    • Cardiac Arrhythmias and Treatments 29
    • Acute Myocardial Infarction Research 27
    • Heart Failure Treatment and Management 23
    • Venous Thromboembolism Diagnosis and Management 23

Daniel Wojdyla

232 papers receiving 16.3k citations

Hit Papers

Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) 2014 · 321 citations
321200620262012201950010001.5k2.0k2.5k

Peers

Daniel Wojdyla
Comparison fields: 5 of 175
  • Internal Medicine 2.2k
  • Obstetrics and Gynecology 4.3k
  • Cardiology and Cardiovascular Medicine 6.4k
  • Pediatrics, Perinatology and Child Health 5.4k
  • Hematology 1.7k
Replace Joel G. Ray with:
Joel G. Ray Canada
Andrew R. Willan Canada
Tom Wilsgaard Norway
Michael G. Shlipak United States
Martin Vessey United Kingdom
Adeera Levin Canada
Brad C. Astor United States
Ethan M. Balk United States
Baha M. Sibai United States
Susan R. Kahn Canada
Daniel Wojdyla relative to Joel G. Ray Canada Joel G. Ray's profile →
Citations per field
00.5×1.5×
Joel G. Ray · 1×
Citations per year

Countries citing papers authored by Daniel Wojdyla

Since Specialization
Citations

This map shows the geographic impact of Daniel Wojdyla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wojdyla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wojdyla more than expected).

Fields of papers citing papers by Daniel Wojdyla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Wojdyla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wojdyla. The network helps show where Daniel Wojdyla may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Wojdyla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Wojdyla Line = papers co-authored together Daniel Wojdyla links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20249
4 20241
5 20241
6 20244
7 20241
8 20243
9 20233
10 20231
11 202124
12 202034
13 201925
14 201959
15
Lower Repeat Revascularization Rates Among Patients With Prior Coronary Artery Bypass Graft Surgery are Due to Lack of Adequate Target Vessels.
20185
16 20161
17
Management and clinical consequences of major bleeding in high-risk patients following an acute coronary syndrome. Is aspirin the problem? : Insights from the APPRAISE-2 trial
20153
18
Digoxin use is associated with higher mortality among patients with atrial fibrillation with and without heart failure : insights from the ARISTOTLE trial
20151
19 2012102
20 201288

About Daniel Wojdyla

Daniel Wojdyla is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Obstetrics and Gynecology, Rheumatology and Pediatrics, Perinatology and Child Health, having authored 245 papers that have together received 17.0k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (69 papers), Antiplatelet Therapy and Cardiovascular Diseases (50 papers), Cardiac Arrhythmias and Treatments (29 papers), Acute Myocardial Infarction Research (27 papers), Heart Failure Treatment and Management (23 papers), Venous Thromboembolism Diagnosis and Management (23 papers), Coronary Interventions and Diagnostics (22 papers) and Systemic Lupus Erythematosus Research (20 papers). The work is most often cited by research in Internal Medicine (2.2k citations), Obstetrics and Gynecology (4.3k citations), Cardiology and Cardiovascular Medicine (6.4k citations), Pediatrics, Perinatology and Child Health (5.4k citations) and Hematology (1.7k citations). Daniel Wojdyla has collaborated with scholars based in United States, Sweden and Argentina. Frequent co-authors include Lale Say, A. Metin Gülmezog̈lu, Khalid S. Khan, Erin McLean, Mary E. Cogswell, Bruno de Benoist, Lars Wallentin, Renato D. Lópes, John H. Alexander and Paul Van Look. Their work appears in journals such as Journal of the American College of Cardiology, Circulation, European Heart Journal, American Heart Journal and Lupus.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026